This company has been acquired
Transphorm Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Transphorm has a total shareholder equity of $18.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $32.7M and $14.4M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$7.95m |
| Aandelen | US$18.25m |
| Totaal verplichtingen | US$14.41m |
| Totaal activa | US$32.66m |
Recente financiële gezondheidsupdates
Recent updates
Transphorm: Deal Likely Done Even If Not Everyone Is Happy
Feb 07Revenues Tell The Story For Transphorm, Inc. (NASDAQ:TGAN)
May 17
Transphorm, Inc. (NASDAQ:TGAN) Just Reported And Analysts Have Been Cutting Their Estimates
Nov 17Transphorm bags ARPA-E contract for four-quadrant GaN switches
Aug 30Transphorm Non-GAAP EPS of -$0.08 in-line, revenue of $5.2M misses by $0.03M
Aug 15Transphorm: Turning Technology Into Revenue
Jul 28Analyse van de financiële positie
Kortlopende schulden: TGAN's short term assets ($21.0M) exceed its short term liabilities ($12.4M).
Langlopende schulden: TGAN's short term assets ($21.0M) exceed its long term liabilities ($2.0M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: TGAN is debt free.
Schuld verminderen: TGAN currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: TGAN has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: TGAN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.4% each year